BlackRock
XGN icon

BlackRock’s Exagen XGN Stock Holding History

BlackRock’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$378K Sell
125,886
-3,727
-3% -$14.4K ﹤0.01% 4596
2025
Q4 		$788K Buy
129,613
+47,246
+57% +$430K ﹤0.01% 4373
2025
Q3 		$905K Buy
82,367
+862
+1% +$7.63K ﹤0.01% 4309
2025
Q2 		$569K Buy
81,505
+48,098
+144% +$292K ﹤0.01% 4409
2025
Q1 		$120K Hold
33,407
– – ﹤0.01% 4726
2024
Q4 		$137K Hold
33,407
– – ﹤0.01% 4704
2024
Q3 		$103K Sell
33,407
-10,159
-23% -$26.3K ﹤0.01% 4662
2024
Q2 		$79.3K Sell
43,566
-11,939
-22% -$20.2K ﹤0.01% 4756
2024
Q1 		$88.3K Sell
55,505
-2,330
-4% -$4.52K ﹤0.01% 4763
2023
Q4 		$115K Sell
57,835
-9,235
-14% -$16K ﹤0.01% 4773
2023
Q3 		$162K Sell
67,070
-6,964
-9% -$17.7K ﹤0.01% 4731
2023
Q2 		$215K Buy
74,034
+1,811
+3% +$5.15K ﹤0.01% 4715
2023
Q1 		$176K Buy
72,223
+575
+0.8% +$1.49K ﹤0.01% 4814
2022
Q4 		$172K Sell
71,648
-2,193
-3% -$5.63K ﹤0.01% 4892
2022
Q3 		$200K Sell
73,841
-150
-0.2% -$837 ﹤0.01% 4971
2022
Q2 		$425K Sell
73,991
-497,322
-87% -$2.9M ﹤0.01% 4822
2022
Q1 		$4.59M Sell
571,313
-12,828
-2% -$111K ﹤0.01% 4015
2021
Q4 		$6.79M Buy
584,141
+253
+0% +$2.96K ﹤0.01% 3867
2021
Q3 		$7.94M Sell
583,888
-1,782
-0.3% -$23.7K ﹤0.01% 3778
2021
Q2 		$8.78M Buy
585,670
+324,932
+125% +$4.98M ﹤0.01% 3685
2021
Q1 		$4.56M Sell
260,738
-624
-0.2% -$11.1K ﹤0.01% 3982
2020
Q4 		$3.45M Buy
261,362
+38,728
+17% +$547K ﹤0.01% 3848
2020
Q3 		$2.41M Sell
222,634
-10,930
-5% -$141K ﹤0.01% 3855
2020
Q2 		$2.9M Buy
233,564
+70,543
+43% +$955K ﹤0.01% 3715
2020
Q1 		$2.6M Buy
163,021
+41,057
+34% +$815K ﹤0.01% 3576
2019
Q4 		$3.1M Buy
+121,964
New +$2.17M ﹤0.01% 3644

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

BlackRock's XGN Position: Q1 2026 in Review

BlackRock reduced its Exagen (XGN) stake by 2.9% in Q1 2026, selling an estimated $14.4K and leaving 125,886 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #4596.

BlackRock first reported a position in XGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.78M in Q2 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • BlackRock held 125,886 shares of Exagen worth $378K as of Q1 2026.
  • BlackRock sold 3,727 Exagen shares in Q1 2026, an estimated $14.4K.
  • Exagen made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4596 holding.
  • BlackRock first reported a position in Exagen in Q4 2019 and has held it in 26 quarters since.
  • BlackRock's Exagen position peaked at $8.78M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.